BrightSpring Health Services, Inc. (BTSG)
(Real Time Quote from BATS)
$11.97 USD
+0.01 (0.08%)
Updated Jul 23, 2024 11:26 AM ET
2-Buy of 5 2
A Value B Growth D Momentum B VGM
BrightSpring Health Services, Inc. (BTSG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$16.04 | $23.00 | $13.00 | 34.11% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for BrightSpring Health Services, Inc. comes to $16.04. The forecasts range from a low of $13.00 to a high of $23.00. The average price target represents an increase of 34.11% from the last closing price of $11.96.
Analyst Price Targets (12)
Broker Rating
BrightSpring Health Services, Inc. currently has an average brokerage recommendation (ABR) of 1.04 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.04 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, 11 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 91.67% and 8.33% of all recommendations. A month ago, Strong Buy made up 91.67%, while Buy represented 8.33%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/BTSG.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 11 | 10 | 10 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.04 | 1.04 | 1.04 | 1.05 | 1.05 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/21/2024 | BTIG | David M Larsen | Not Available | Strong Buy |
5/6/2024 | Wells Fargo Securities | Stephen Baxter | Strong Buy | Strong Buy |
3/6/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
3/4/2024 | Goldman Sachs | Jamie Perse | Strong Buy | Strong Buy |
2/20/2024 | Guggenheim Securities | Jack D Wallace | Not Available | Strong Buy |
2/20/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
2/20/2024 | SVB Securities | Whit Mayo | Not Available | Strong Buy |
2/20/2024 | UBS | Aj Rice | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.04 |
ABR (Last week) | 1.04 |
# of Recs in ABR | 12 |
Average Target Price | $16.04 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 98 of 252 |
Current Quarter EPS Est: | 0.18 |